
On Monday an association of American realtors asked the US Supreme Court to overturn a US appeals court ruling that has revived the challenge for the real estate platform’s policy it claims was implemented in to restrict competition.
Cooley and other firm lawyers filed a petition on Friday to overturn the April ruling in the US 9th District Court of Appeals, based in San Francisco. An appeals court restored claims from ThePLS.com after a Los Angeles federal judge dismissed a complaint against the National Association of Realtors (NAR).
PLS, which currently operates as TheNLS.com, endeavors to offer “pocket money” or exclusive home deals that do not also appear on member-operated NAR “multi-offer”
But the 2019 NAR’s ‘Clear Collaboration Policy’ says that a member of the association who wanted to list a property on PLS was also required within one business day to list the house in a database linked to the NAR.
Chicago-based attorneys told judges that the 9th Circuit panel misapplied US Supreme Court precedent in the PLS ruling. NAR lawyers also alleged that the PLS platform was harmful to consumers.
“PLS wants to pursue a business model that will harm buyers and sellers by introducing more exclusivity and secrecy into the home buying process through” pocket letters “shown only to a privileged few,” wrote Cooley’s Adam Gershenson. NAR policy “provides consumers with universal access to market information,” he said.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas